Moreover, QUE significantly down-regulated ABCB1 expression in KATOIII/OxR, an oxaliplatin-resistant GC cell line, and increased the apoptosis rate of KATOIII/OxR cells (83). This evidence concerns the gene ABCB1 and gastric cancer.